GALLAGHER JOHN R sold $11K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 431 shares of TRUPANION, INC. (TRUP) at $25.35 on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Jul 1, 2026, 11:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 11:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

Confirms the COO reduced holdings by ~$10.9k; typically not a catalyst for re-rating absent additional fundamental news.

02

Market read

Traders may log the sale for sentiment/positioning, but it is unlikely to drive price without corroborating fundamentals.

03

What to watch

The filing does not indicate intent beyond the plan; without context on prior grants/sales cadence, it’s hard to infer directionality.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-01; sale executed 2026-06-29

Background

SEC Form 4 discloses an officer’s open-market sale executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

TRUP insider filing shows COO John R. Gallagher sold 431 shares at $25.35 on 2026-06-29 under a 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect would be second-order via sentiment rather than fundamentals.

Evidence & confidence

Form 4 is a primary disclosure, but the transaction is explicitly under a pre-arranged 10b5-1 plan and is small relative to typical market moves.

Market effects

No clear sector read-through from a single routine 10b5-1 sale.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may watch for follow-on sales or changes in buying behavior.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction was disclosed on Form 4.

  • GALLAGHER JOHN R

    Chief Operating Officer who sold 431 shares.

  • Rule 10b5-1 plan

    Pre-arranged plan that generally reduces informational content of the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMedAI 8/10

Why is Trupanion (TRUP) stock soaring today

Trupanion (TRUP) shares rose 6.5% after reporting Q3 2026 revenue of $405.6M, up 10.5% YoY, and EPS of $0.21, both exceeding estimates. The company also reported strong cash flow and share repurchases. The stock has been volatile, with a 52-week low reached after a Q4 2025 EPS miss.

$TRUPHighAI 8/10

Trupanion Q3 Earnings Call Highlights

Trupanion (TRUP) expects double-digit veterinary cost inflation through 2027, with stable rate increases supporting retention. Q3 costs for paying veterinary invoices were $200.6M (69.7% of revenue). Full-year 2026 revenue is projected at $1.59B-$1.597B, with Q4 revenue expected at $407M-$414M. The company repurchased 830,000 shares for $25M and plans new digital insurance and pet food offerings.

$TRUPMed

Trupanion Inc (TRUP) Q3 2026 Earnings Call Highlights: Record Adjusted Operating Income

Trupanion Inc (TRUP) reported Q3 2026 earnings with record adjusted operating income of $47M, up 15% YoY. Net new pet additions rose 28% YoY to over 20,500, while acquisition cost per pet declined. Retention improved to 98.38%, and free cash flow hit $28.5M. The company is investing in growth initiatives like Landspath pet food, expected to launch in 2027. Challenges include elevated veterinary industry inflation and increased fixed expenses.

$TRUPHigh

Trupanion Reports Third Quarter 2026 Results

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Third Quarter 2026 Results SEATTLE, WA. November 5, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. “Our third-quart

$TRUPMedAI 8/10

Property & Casualty Insurance Stocks Q2 Results: Benchmarking Trupanion (NASDAQ:TRUP)

Essent Group (ESNT) reported Q2 revenues of $362.7M, up 13.6% YoY, beating estimates. Radian Group (RDN) reported $580.7M in revenues, up 95.7% YoY, but missed EPS estimates. Fidelity National Financial (FNF) reported $4.05B in revenues, up 11.4% YoY, beating estimates. W. R. Berkley (WRB) reported $3.72B in revenues, up 1.2% YoY, missing revenue estimates but beating EPS estimates.